Table 2 Early and mid-term results (N=15).

Follow-up duration, mo	40 (15–72)
Early mortality	1 (6.7%)
Operative death	0
Stroke	1
Early morbidities
Cerebrovascular event	1 (6.7%)
Stroke	1 (6.7%)
TIA	0
Spinal cord injury	0
Lower limb ischemia	1 (6.7%)
Cardiac event (LOS)	0
Respiratory complication	3 (20.0%)
Mediastinitis	0
Sepsis	0
Intestinal ischemia	0
Kinking of FET	1 (6.7%)
dSINE	1 (6.7%)
Mid-term mortality	3 (21.4%)
Heart failure	1 (7.1%)
Aorto-esophageal fistula	1 (7.1%)
Lung hemorrhage	1 (7.1%)
Mid-term morbidities
Cerebrovascular event	0
Spinal cord injury	0
dSINE	4 (28.5%)
Aorto-esophageal fistula	3 (21.4%)
Re-operation	7 (50.0%)
Planned operation	3 (21.4%)
Re-entry closure	1 (7.1%)
False lumen occlusion	1 (7.1%)
Descending aortic replacement	1 (7.1%)
Unplanned operation	4 (28.5%)
TEVAR due to dSINE	4 (28.5%)

TIA: transient ischemic attack; LOS: low output syndrome; FET: frozen elephant trunk; dSINE: distal stent induced new entry; TEVAR: thoracic endovascular aortic repair